Abstract:Objective :— This study is to explore the effect of valsartan-eluting stents on neointima formation after stenting and to elucidate possible mechanisms how locally used valsartan prevents in-stent restenosis (ISR). METHOD: valsartan- and carriereluting stents were manufactured by using multi-layer-coated technology. Bare stents, carrier-eluting stents and valsartan– eluting stents were implanted into the abdominal aortas of the rabbits respectively. Quantitative angiography (QA) before, immediately after and 3 months after stent implantation were compared between the groups of bare (n=8), carrier-eluting (n=8) and valsartan-eluting stent (n=10), which allows the comparison of vascular diameters of aortas as well as indices of vascular neointimal formation, i.e. luminal area (LA), neointimal area (NIA), inner elastic membrane luminal area (IELA) and the maximal inner-membrane thickness (MIT) in 15 rabbits. α-Actin protein expression were detected by Envision two-step immunohistochemistry. Mean positive indices (MPI) of the above protein were analyzed semi-quantatively by IMS(Information Management System) cell image analysis system. MPI=positive area×OD (optical density). Collagen deposition in neointima was observed through MASSON stain among the three groups. Result:— the mean aortic diameters were similar in the three groups:bare stents group(n=8), carrier-eluting stents group(n=8) and valsartan eluting stents group(n=10) measured by QA at different time. A larger luminal area and a less neointimal hyperplasia in valsartan eluting-stents group was found compared with the other two groups. The mean luminal areas were 4345548±125822um2; 4302061±167952 um2; 5016269±207934um2 respectively. The mean neointimal areas were 1119635±163503um2; 1135636±136555um2; 441577±74099um2 and the mean maximal inner-membrane thickness were 210±30um;192±21um; 116±12um respectively. α-Actin protein expression was significantly lower in neointima of valsartan eluting-stents group than the other two groups. Through MASSON stain we found that Collagen was much richer in neointima of bare stents group and carrier-eluting stents group than valsartan eluting-stents group. Conclusion:— Valsartan eluting-stents inhibited neointimal hyperplasia after stenting by decreasing collagen deposition and smooth muscle cell proliferation. Therefore it would be potentially effective in preventing in-stent restenosis. Abbreviations:— Quantitative angiography (QA), luminal area (LA), neointimal area (NIA), inner elastic membrane luminal area (IELA), the maximal inner-membrane thickness (MIT), Mean positive indices (MPI), optical density (OD), Drugeluting stents (DES), in-stent restenosis(ISR), percutaneous transluminal coronary angioplasty (PTCA), angiotensin α type 2 receptor (AT2).

AS-115: Short-Term Effect of Tetramethylpyrazine-Eluting Stents on Neointimal Hyperplasia in Renal Arteries

Effects of Tetramethylpyrazine-Eluting Stent on Neointimal Hyperplasia after Renal Artery Stenting

The Experimental Study of Tetramethylpyrazine-Eluting Stents on Preventing In-stent Intima Hyperplasia

Tetramethylpyrazine-Eluting Stents Prevented In-Stent Restenosis in a Porcine Model

Effect of trimetazidine for PCI were related myocardial ischemia-reperfusion injury and prognosis

Experimental Study of Preventive Effect of Tetramethylpyrazine-Eluting Stents on In-Stent Restenosis

Biocompatibility of Tetramethylpyrazine-Eluting Stents in Normal Porcine Coronary Arteries.

The efficacy of tetramethylpyrazine-eluting stents on inhibiting neointima formation in porcine coronary arteries]

Long-Term Effects of Drug-Eluting Stents Versus Bare Metal Stents on Patients with Acute St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes of 3-Year Clinical Follow-Up

Prevention of Neointimal Formation after Angioplasty Using Tetramethylpyrazine-Coated Balloon Catheters in a Rabbit Iliac Artery Model.

Proliferation and Apoptosis of Smooth Muscle Cells after Implantation of Tetramethylpyrazine-Eluting Stents in the Porcine Coronary Artery

Influence of Valsartan-Eluting Stent on Neointima Formation

Effects of Intensive Antiplatelet Therapy for Patients with High On-Treatment Platelet Reactivity after Coronary Stent Implantation

Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation

Effect and Mechanism of Tetramethylpyrazine on Antithrombotic

Clinical Study of Early Injury of Coronary Artery after Percutaneous Transluminal Coronary Stent Implantation

Study on the effect of restenosis of the stent coated with PEG-PLA-PGL/RGD after PCI

Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials.

Effect of Different Doses of Cilostazol Intensive Antiplatelet Therapy on the Patients with High On-treatment Platelet Reactivity after Coronary Stent Implantation

Temporary Placement of a Paclitaxel or Rapamycin-Eluting Stent is Effective to Reduce Stenting Induced Inflammatory Reaction and Scaring in Benign Cardia Stricture Models.

Effectiveness and Safety of Cilostazol for Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis